Dr. Ogan Gurel serves as Chief Science Officer for FLITE Material Sciences Corp. (U.S./Canada) and also holds academic appointments at the Solbridge International School of Business and DGIST (Daegu Gyeongbuk Institute of Science & Technology), with previous DGIST positions as Vice-Chair & Distinguished Invited Professor in the Management of Innovation program. In the innovation world, Dr. Gurel is also Chief Strategy Officer at CTCELLS (Daegu, South Korea), Chief Marketing Officer for Eidware / SoundMind (Seoul), Advisor for the CREST-Malaysia Digital Health Cluster and a Venture Partner at The Yozma Group, with previous executive roles as Chief Scientific Officer for FRT – Field Robot Technology, CEO at NovumWaves (Seoul), Acting Chief Medical Officer at Nessa Hearing (Singapore), and Advisor at Frasen (Seoul). Ogan served over four years as a Director in the CTO office (MOT & Open Innovation groups) at the Samsung Advanced Institute of Technology (SAIT) and prior to that was VP & Medical Director at Sg2, a leading U.S.-based healthcare consultancy and an Associate at Booz, Allen & Hamilton. Dr. Gurel’s over 35 years of experience spans multiple sectors: biomedical science, clinical medicine, strategy consulting, marketing, business development, executive management, marketing, and R&D management, with domain expertise in medical devices, digital healthcare, healthcare IT, molecular biophysics, and medical imaging. Prior to surgical training at the Massachusetts General Hospital, he obtained an MD degree Alpha Omega Alpha from the Columbia University College of Physicians & Surgeons, also doing graduate work in structural biology (M.Phil degree) and earned a Bachelor’s in Biochemical Sciences cum laude from Harvard University. Authoring 14 peer-reviewed scholarly papers, presenting nearly 200 conference proceedings and co-inventor on ten patent applications (four granted), and an acclaimed novel, Waves, Dr. Gurel has also given keynote addresses and other speeches at business and scientific conferences and seminars worldwide.